More Evidence Backs CBD For Kids’ Rare Epilepsy

TUESDAY, April 30, 2019 (HealthDay News) — There’s new data supporting the use of Epidiolex — the first cannabidiol (CBD) medicine approved by the U.S. Food and Drug Administration — to help curb a form of epilepsy. The research found that the drug reduced seizures by nearly half in children with Dravet syndrome, a rare and severe form of the neurological disorder. The FDA approved Epidiolex last fall for the treatment of Dravet syndrome and another rare but severe form of childhood epilepsy, Lennox-Gastaut syndrome. The new study was funded by GW Research Ltd. More Evidence Backs CBD For Kids’ Rare Epilepsy

thumbnail courtesy of webmd.com